Literature DB >> 22273505

Mechanisms of FGFR-mediated carcinogenesis.

Imran Ahmad1, Tomoko Iwata, Hing Y Leung.   

Abstract

In this review, the evidence for a role of fibroblast growth factor receptor (FGFR) mediated signalling in carcinogenesis are considered and relevant underlying mechanisms highlighted. FGF signalling mediated by FGFR follows a classic receptor tyrosine kinase signalling pathway and its deregulation at various points of its cascade could result in malignancy. Here we review the accumulating reports that revealed the association of FGF/FGFRs to various types of cancer at a genetic level, along with in vitro and in vivo evidences available so far, which indicates the functional involvement of FGF signalling in tumour formation and progression. An increasing number of drugs against the FGF pathways is currently in clinical testing. We will discuss the strategies for future FGF research in cancer and translational approaches.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22273505     DOI: 10.1016/j.bbamcr.2012.01.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  60 in total

1.  A New Method to Study Heterodimerization of Membrane Proteins and Its Application to Fibroblast Growth Factor Receptors.

Authors:  Nuala Del Piccolo; Sarvenaz Sarabipour; Kalina Hristova
Journal:  J Biol Chem       Date:  2016-12-07       Impact factor: 5.157

2.  Illuminating the molecular mechanisms of tyrosine kinase inhibitor resistance for the FGFR1 gatekeeper mutation: the Achilles' heel of targeted therapy.

Authors:  Christal D Sohl; Molly R Ryan; BeiBei Luo; Kathleen M Frey; Karen S Anderson
Journal:  ACS Chem Biol       Date:  2015-02-24       Impact factor: 5.100

3.  Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors.

Authors:  Tomohiro Nishina; Shunji Takahashi; Ryota Iwasawa; Hidehisa Noguchi; Masayuki Aoki; Toshihiko Doi
Journal:  Invest New Drugs       Date:  2017-09-30       Impact factor: 3.850

4.  Methods to assess anticancer immune responses in orthotopic bladder carcinomas.

Authors:  Randy F Sweis
Journal:  Methods Enzymol       Date:  2019-10-24       Impact factor: 1.600

5.  Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.

Authors:  Joachim Weischenfeldt; Taronish Dubash; Alexandros P Drainas; Balca R Mardin; Yuanyuan Chen; Adrian M Stütz; Sebastian M Waszak; Graziella Bosco; Ann Rita Halvorsen; Benjamin Raeder; Theocharis Efthymiopoulos; Serap Erkek; Christine Siegl; Hermann Brenner; Odd Terje Brustugun; Sebastian M Dieter; Paul A Northcott; Iver Petersen; Stefan M Pfister; Martin Schneider; Steinar K Solberg; Erik Thunissen; Wilko Weichert; Thomas Zichner; Roman Thomas; Martin Peifer; Aslaug Helland; Claudia R Ball; Martin Jechlinger; Rocio Sotillo; Hanno Glimm; Jan O Korbel
Journal:  Nat Genet       Date:  2016-11-21       Impact factor: 38.330

6.  Polymorphisms of FGFR1 in HBV-related hepatocellular carcinoma.

Authors:  Haiyang Xie; Chunyang Xing; Bajin Wei; Xiao Xu; Liming Wu; Jian Wu; Leiming Chen; Guoqiang Cao; Hai Chen; Xueqin Meng; Shengyong Yin; Lin Zhou; Shusen Zheng
Journal:  Tumour Biol       Date:  2015-06-12

7.  Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.

Authors:  Erik H Knelson; Angela L Gaviglio; Alok K Tewari; Michael B Armstrong; Karthikeyan Mythreye; Gerard C Blobe
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.

Authors:  Joshua C Anderson; Christine W Duarte; Karim Welaya; Timothy D Rohrbach; Markus Bredel; Eddy S Yang; Nirmal V Choradia; Jaideep V Thottassery; George Yancey Gillespie; James A Bonner; Christopher D Willey
Journal:  Radiother Oncol       Date:  2014-05-08       Impact factor: 6.280

9.  Homology modeling and virtual screening studies of FGF-7 protein-a structure-based approach to design new molecules against tumor angiogenesis.

Authors:  Rajender Vadija; Kiran Kumar Mustyala; Navaneetha Nambigari; Ramasree Dulapalli; Rama Krishna Dumpati; Vishwanath Ramatenki; Santhi Prada Vellanki; Uma Vuruputuri
Journal:  J Chem Biol       Date:  2016-06-18

10.  FGFR and PTEN signaling interact during lens development to regulate cell survival.

Authors:  Blake R Chaffee; Thanh V Hoang; Melissa R Leonard; Devin G Bruney; Brad D Wagner; Joseph Richard Dowd; Gustavo Leone; Michael C Ostrowski; Michael L Robinson
Journal:  Dev Biol       Date:  2016-01-05       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.